EYPT

EYPT

USD

EyePoint Pharmaceuticals Inc. Common Stock

$12.390+0.260 (2.143%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$12.130

Máximo

$12.950

Mínimo

$11.960

Volume

4.59M

Fundamentos da empresa

Capitalização de mercado

1.0B

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

1.08M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $3.91Atual $12.390Máximo $14.91

Notícias relacionadas

GlobeNewswire

EyePoint Announces Pricing of Public Offering

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with

Ver mais
EyePoint Announces Pricing of Public Offering
GlobeNewswire

EyePoint Announces Proposed Public Offering of Common Stock

WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with

Ver mais
EyePoint Announces Proposed Public Offering of Common Stock
GlobeNewswire

EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

– DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New preclinical data

Ver mais
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.